131 related articles for article (PubMed ID: 3905472)
1. Immunocytochemical localization of insulin-immunoreactive cells in the pancreatic ducts of rats treated with trypsin inhibitor.
Weaver CV; Sorenson RL; Kaung HC
Diabetologia; 1985 Oct; 28(10):781-5. PubMed ID: 3905472
[TBL] [Abstract][Full Text] [Related]
2. Morphometry and elemental analysis of rat exocrine pancreas following administration of trypsin inhibitor.
Sato T; Herman L
Acta Anat (Basel); 1990; 137(1):65-76. PubMed ID: 2305633
[TBL] [Abstract][Full Text] [Related]
3. Effects of trypsin inhibitor on the remnant pancreas after 85 percent pancreatectomy in rats.
Baba N; Suzuki T; Tobe T
Jpn J Surg; 1984 Sep; 14(5):420-31. PubMed ID: 6392657
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophy and hyperplasia in the endocrine and exocrine pancreas of rats fed soybean trypsin inhibitor or repeatedly injected with pancreozymin.
Yanatori Y; Fujita T
Arch Histol Jpn; 1976 Mar; 39(1):67-78. PubMed ID: 779717
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral administration of trypsin inhibitor and repeated injections of pancreozymin on the insulin and glucagon contents of rat pancreas.
Fujita T; Matsunari Y; Sato K; Hayashi M; Koga Y
Endocrinol Jpn; 1979 Feb; 26(1):35-9. PubMed ID: 436800
[TBL] [Abstract][Full Text] [Related]
6. [The influence of truncal vagotomy or surgical sympathectomy on the pancreatic trophic effect of trypsin inhibitor upon normal rats and major pancreatectomized rats].
Aki T; Baba N; Tobe T; Suzuki T; Nishimura I; Tsai G
Nihon Geka Gakkai Zasshi; 1989 Apr; 90(4):586-97. PubMed ID: 2474751
[TBL] [Abstract][Full Text] [Related]
7. Reversal of diabetes in rats using GLP-1-expressing adult pancreatic duct-like precursor cells transformed from acinar to ductal cells.
Lee J; Wen J; Park JY; Kim SA; Lee EJ; Song SY
Stem Cells Dev; 2009 Sep; 18(7):991-1002. PubMed ID: 19125629
[TBL] [Abstract][Full Text] [Related]
8. Modifying effects of soybean trypsin inhibitor on development of eosinophilic nodules and basophilic foci in the exocrine pancreas of male Sprague-Dawley rats treated with 4-hydroxyaminoquinoline 1-oxide.
Furukawa F; Imaida K; Imazawa T; Hayashi Y; Takahashi M
Jpn J Cancer Res; 1992 Jan; 83(1):40-4. PubMed ID: 1544872
[TBL] [Abstract][Full Text] [Related]
9. The effect of feeding soybean trypsin inhibitor and repeated injections of cholecystokinin on rat pancreas.
Temler RS; Dormond CA; Simon E; Morel B
J Nutr; 1984 Jun; 114(6):1083-91. PubMed ID: 6202862
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Insulin-Immunoreactive Cells and Endocrine Cells Within the Duct System of the Adult Human Pancreas.
Li R; Zhang X; Yu L; Zou X; Zhao H
Pancreas; 2016; 45(5):735-42. PubMed ID: 26580455
[TBL] [Abstract][Full Text] [Related]
11. Oral trypsin-inhibitor-induced improvement of the exocrine and endocrine pancreatic functions in alloxan diabetic rats.
Ihse I; Lundquist I; Arnesjö B
Scand J Gastroenterol; 1976; 11(4):363-8. PubMed ID: 779003
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormones promote endocrine differentiation at expenses of exocrine tissue.
Aïello V; Moreno-Asso A; Servitja JM; Martín M
Exp Cell Res; 2014 Apr; 322(2):236-48. PubMed ID: 24503054
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophy and hyperplasia of the rat pancreas produced by short-term dietary administration of soya-derived protein and soybean trypsin inhibitor.
Smith JC; Wilson FD; Allen PV; Berry DL
J Appl Toxicol; 1989 Jun; 9(3):175-9. PubMed ID: 2745924
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
Marks WH; Ohlsson K; Polling A
Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
[TBL] [Abstract][Full Text] [Related]
15. In vivo depletion of pancreatic acinar tissue simplifies islet preparation for transplantation.
Al-Abdullah IH; Vulin CL; Kumar MS
Transplantation; 1996 Sep; 62(6):781-7. PubMed ID: 8824478
[TBL] [Abstract][Full Text] [Related]
16. Studies on the reversibility of oral trypsin inhibitor induced changes of rat pancreatic exocrine enzyme activity and insulin secretory capacity.
Ihse I; Arnesjö B; Lundquist I
Scand J Gastroenterol; 1975; 10(3):321-6. PubMed ID: 806112
[TBL] [Abstract][Full Text] [Related]
17. Effects of caerulein and trypsin inhibitors on the endocrine mouse pancreas.
Bonnevie-Nielsen V
Acta Endocrinol (Copenh); 1981 Feb; 96(2):227-34. PubMed ID: 6162352
[TBL] [Abstract][Full Text] [Related]
18. 31P-NMR studies of energy metabolites in rat pancreas treated with trypsin inhibitor.
Komabayashi T; Watanabe K; Izawa T; Tsuboi M
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):249-52. PubMed ID: 2429352
[TBL] [Abstract][Full Text] [Related]
19. Trypsin inhibitor ingestion-induced urinary indican excretion and pancreatic acinar cell hypertrophy.
Anderson RL; Maurer JK; Francis WR; Buring SL
Nutr Cancer; 1986; 8(2):133-9. PubMed ID: 3085073
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of trypsinogen and trypsin in acute and chronic pancreatitis.
Aho HJ; Putzke HP; Nevalainen TJ; Löbel D; Pelliniemi LJ; Dummler W; Suonpää AK; Tessenow W
Digestion; 1983; 27(1):21-8. PubMed ID: 6350076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
